GB1432784A - Orally administrable pharmaceutical compositions - Google Patents

Orally administrable pharmaceutical compositions

Info

Publication number
GB1432784A
GB1432784A GB5273473A GB5273473A GB1432784A GB 1432784 A GB1432784 A GB 1432784A GB 5273473 A GB5273473 A GB 5273473A GB 5273473 A GB5273473 A GB 5273473A GB 1432784 A GB1432784 A GB 1432784A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
orally administrable
nov
administrable pharmaceutical
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5273473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of GB1432784A publication Critical patent/GB1432784A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB5273473A 1972-11-18 1973-11-13 Orally administrable pharmaceutical compositions Expired GB1432784A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11602172A JPS4971127A (de) 1972-11-18 1972-11-18

Publications (1)

Publication Number Publication Date
GB1432784A true GB1432784A (en) 1976-04-22

Family

ID=14676810

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5273473A Expired GB1432784A (en) 1972-11-18 1973-11-13 Orally administrable pharmaceutical compositions

Country Status (6)

Country Link
JP (1) JPS4971127A (de)
BE (1) BE807312A (de)
CA (1) CA1036072A (de)
DE (1) DE2357389A1 (de)
FR (1) FR2206943B1 (de)
GB (1) GB1432784A (de)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4263313A (en) 1977-02-24 1981-04-21 Kali-Chemie Pharma Gmbh Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US5156842A (en) * 1987-06-19 1992-10-20 Elan Corporation, Plc Liquid suspension for oral administration
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
FR2500302B1 (fr) * 1981-02-25 1985-11-15 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
JPS5877810A (ja) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS60153758A (ja) * 1984-01-23 1985-08-13 Kao Corp 油脂組成物
FR2569561B1 (fr) * 1984-08-30 1990-05-18 Oreal Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone
JP2537658B2 (ja) * 1987-04-13 1996-09-25 小野薬品工業株式会社 エステル類またはアミド類を有効成分として含有する新規な製剤
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP5666760B2 (ja) * 2005-03-31 2015-02-12 サントリーホールディングス株式会社 リグナン類化合物含有組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (de) *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4263313A (en) 1977-02-24 1981-04-21 Kali-Chemie Pharma Gmbh Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US5156842A (en) * 1987-06-19 1992-10-20 Elan Corporation, Plc Liquid suspension for oral administration
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds

Also Published As

Publication number Publication date
BE807312A (fr) 1974-03-01
FR2206943A1 (de) 1974-06-14
DE2357389A1 (de) 1974-05-22
AU6254373A (en) 1975-05-15
FR2206943B1 (de) 1977-09-02
CA1036072A (en) 1978-08-08
JPS4971127A (de) 1974-07-10

Similar Documents

Publication Publication Date Title
GB1432784A (en) Orally administrable pharmaceutical compositions
CA2132012A1 (en) Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
DK128283A (da) Farmaceutiske praeparater, der kan administreres oralt
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
KR880010758A (ko) 서방성 제제
DE3573884D1 (en) Substained release tablets and method for preparation thereof
MC1969A1 (fr) Procedes pour preparer des composes antitumoraux,formulation pharmaceutique contenant ces composes,leurs utilisations en medecine et pharmacie,et composes intermediaires pour leur preparation
DK0421541T3 (da) Tabletstruktur, som kan deles
WO2000025756A3 (de) Arzneimittel zur topischen behandlung entzündlicher darmerkrankungen
ES531346A0 (es) Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph
EP0271151A3 (de) Azumolen-Dosisformen
IE35419B1 (en) Muscle-relaxant compositions
IE33949B1 (en) Compositions for treating gastrointestinal disorders
AU474505B2 (en) Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment
GB1327467A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
Ota et al. A double-blind comparison of haloperidol oral concentrate, haloperidol solutabs and placebo in the treatment of chronic schizophrenia.
MY129255A (en) A new physical form of artemisinin and its use in the production of pharmaceuticals
KR790000319B1 (en) Process of manufacturing 2,4-diamino-pyrimidine with a sulphonamide
GB1454390A (en) Nasal decongestants
TH14177A (th) อนุพันธ์ของเซฟฟาโลสปอริน
JO1881B1 (en) Formula II for multi unit disc calibration
TH360B (th) น้ำลูกยอผสมน้ำผึ้ง
ES8704080A1 (es) Metodo para producir una tableta farmaceutica revestida esencialmente con un terpolimero de poli (cloruro de vinilo) poli (acetato de vinilo) y poli (alcohol vinilico)
JPS61243016A (ja) 柱状の有効成分含有部分をもつ錠剤

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee